Statistics
Publications
17
Citations
2.2K
H-Index
16
Active since
1985
Beverly D. Smolich is an author at Maxygen (United States) specializing in life sciences, oncology, and molecular oncology.
Publications per year
1985–2020
17
17
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase
Kevin Yee, A O’Farrell, Beverly D. Smolich et al. · Blood · 2002 · 164 citations
1–5 of 17